Skip to main content
. 2021 Apr 28;12:2460. doi: 10.1038/s41467-021-22814-9

Fig. 4. Plasmid-encoded resistance.

Fig. 4

A Antibiotic resistance phenotypes of PA01:p110820 transformants compared to a plasmid-free PA01 control. Plasmid carriage increased resistance to meropenem and piperacillin-tazobactam to at least 32 mg/L, exceeding the EUCAST clinical breakpoints (meropenem, 8 mg/L; piperacillin-tazobactam, 16 mg/L). B Changes in plasmid copy number during infection. Plotted points show the mean plasmid copy number of lung (blue) and gut (beige) isolates from each time point (+/− s.e.m.; n = 10–12 isolates), excluding two genetically divergent gut isolates that are plotted separately. The second wave of lung infection was associated with a reduced plasmid copy number compared to the initial infection (two-tailed t57 = 8.15, P < 0.0001). C Fitness effects of plasmid carriage were assayed by measuring the growth rate of PA01 and PA01:p110820 in antibiotic-free culture medium (n = 11 replicates/strain). Plasmid carriage reduced growth rate (two-tailed t21 = 2.48, P = 0.0215). D Plasmid copy number of lung isolates according to genotype (mean + /− s.e.m.; n = 7–24 isolates per genotype). Source data are provided as a Source Data file.